ArticleACS omega2025
Dual-Action κ-Carrageenan: A Novel Capping Agent and Dopant Source for Enhanced Photocatalytic ZnO Nanoparticles in Azo Dye and Cr(VI) Degradation.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eco-Friendly Bioinspired Synthesis and Environmental Applications of Zinc Oxide Nanoparticles Mediated by Natural Polysaccharide Gums: A Sustainable Approach to Nanomaterials Fabrication.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal oxide nanoparticles synthesized via green routes are increasingly recognized for their potential in water treatment applications due to their enhanced photocatalytic properties. This study presents a novel approach for the synthesis of zinc oxide nanoparticles (ZnO NPs) using κ-carrageenan derived from alkali-treated
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.